148 related articles for article (PubMed ID: 35396948)
1. Radiation and chemotherapy variable response induced by tumor cell hypoxia: impact of radiation dose, anticancer drug, and type of cancer.
Ibrahim AM; Nady S; Shafaa MW; Khalil MM
Radiat Environ Biophys; 2022 May; 61(2):263-277. PubMed ID: 35396948
[TBL] [Abstract][Full Text] [Related]
2. Regulation of hypoxia-induced mRNA expressions of HIF-1alpha and osteopontin and in vitro radiosensitization by tirapazamine in human nasopharyngeal carcinoma HNE-1 and CNE-1 cells.
Xu P; Huang JM; Ren Y; Zha X; Deng BF; Wu JH; Lang JY
Chin J Cancer; 2010 Feb; 29(2):126-30. PubMed ID: 20109337
[TBL] [Abstract][Full Text] [Related]
3. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
5. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
6. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
[TBL] [Abstract][Full Text] [Related]
8. Tumor cells upregulate normoxic HIF-1α in response to doxorubicin.
Cao Y; Eble JM; Moon E; Yuan H; Weitzel DH; Landon CD; Nien CY; Hanna G; Rich JN; Provenzale JM; Dewhirst MW
Cancer Res; 2013 Oct; 73(20):6230-42. PubMed ID: 23959856
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the doxorubicin response by hypoxia-inducible factor-1α is strictly dependent on oxygen concentrations under hypoxic conditions.
Osada-Oka M; Kuwamura H; Imamiya R; Kobayashi K; Minamiyama Y; Takahashi K; Tanaka M; Shiota M
Eur J Pharmacol; 2022 Apr; 920():174845. PubMed ID: 35202675
[TBL] [Abstract][Full Text] [Related]
10. The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells.
Sasabe E; Zhou X; Li D; Oku N; Yamamoto T; Osaki T
Int J Cancer; 2007 Jan; 120(2):268-77. PubMed ID: 17066447
[TBL] [Abstract][Full Text] [Related]
11. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
[TBL] [Abstract][Full Text] [Related]
12. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.
Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH
Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300
[TBL] [Abstract][Full Text] [Related]
13. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
14. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
Palayoor ST; Tofilon PJ; Coleman CN
Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells.
Mitani T; Ito Y; Harada N; Nakano Y; Inui H; Ashida H; Yamaji R
J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):122-8. PubMed ID: 24975222
[TBL] [Abstract][Full Text] [Related]
17. Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro.
Patras L; Fens MHAM; Vader P; Barendrecht A; Sesarman A; Banciu M; Schiffelers R
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824972
[TBL] [Abstract][Full Text] [Related]
18. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
Adamski J; Price A; Dive C; Makin G
PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
[TBL] [Abstract][Full Text] [Related]
20. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells.
Palayoor ST; Mitchell JB; Cerna D; Degraff W; John-Aryankalayil M; Coleman CN
Int J Cancer; 2008 Nov; 123(10):2430-7. PubMed ID: 18729192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
